PETS' fiscal first-quarter 2027 sales decline year over year, but lower costs, stronger recurring sales and new partnerships offer signs of progress.
PetMed Express, Inc. (PETS) Q1 2027 Earnings Call Prepared Remarks Transcript
PetMed says FY26 reset is working. Its Q4 sales top estimates, margins improve, and it stays independent after $4-$4.25 offers and touts B2B expansion.
PetMed (PETS) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.56 per share a year ago.
PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript
Shore Capital has highlighted a growing divergence within Pets at Home Group PLC (LSE:PETS), the UK's largest specialist pet retailer, arguing that the higher-margin veterinary division is being undervalued by a market focused on weakness in the retail business. The broker's assessment came as Pets at Home reported full-year results showing group consumer revenue up 1% to £1.98 billion but adjusted pre-tax profit down roughly 30% to £93 million.
Pets at Home Group PLC (LSE:PETS) reported an acceleration in sales growth at its shops in the new financial year as the pet care retailer backed market profit expectations for 2027 and rejigged its shareholder returns policy. A "rebased" shareholder returns policy sees the dividend cut to 7.4p from 13p, with an increasing emphasis on share buybacks, starting with a £50 million programme over the next 12 months.
Pets at Home Group PLC (LSE:PETS) has appointed former Waitrose managing director James Bailey as its new chief executive, starting in March. The retailer parted company with previous CEO Lyssa McGowan in September after issuing its second profit warning of the year.
Pets at Home Group PLC (LSE:PETS) results and strategy update offered some encouragement, but not all analysts saw it as changing the picture much. Peel Hunt analyst Jonathan Pritchard said the interims "reflected a poor half of trading on the retail side, and a solid half in vets".
Despite news of further weak trading, Pets at Home's share price spiked on Wednesday as the retailer averted another confidence-crushing profit warning.
Pets at Home Group PLC (LSE:PETS) reported a decline in first-half profit and launched a four-part turnaround strategy for its retail division, with interim executive chair Ian Burke setting out plans to stabilise performance following the sudden exit of CEO Lyssa McGowan in September. Retail underlying profit before tax fell 84.1% to £3.5 million in the first half, against a broadly flat market, while consumer revenue edged up 0.7% to £1.06 billion, driven by a 6.7% increase in veterinary sales as retail revenue declined 2.3%.
Analysts at Jefferies have clipped their price target for Pets at Home Group PLC (LSE:PETS), from 330p to 250p, after last week's profit warning. The American broker, nevertheless, is sticking with a 'Buy', for now at least, saying the share's value is supported by the group's Veterinary division.